Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-11-21
pubmed:abstractText
The present studies were undertaken to determine the testicular cell type(s) affected by the antispermatogenic indenopyridine CDB-4022. At the oral threshold dose (2.5 mg/kg), CDB-4022 induced infertility in all males. CDB-4022 did not alter (P > 0.05) Leydig cell function as assessed by circulating testosterone, seminal vesicle, and ventral prostate weights or body weight gain compared to controls. Conversely, CDB-4022 reduced (P < 0.05) testicular weight, spermatid head counts, and percentage of seminiferous tubules undergoing spermatogenesis. In a second study, adult male rats received a maximally effective oral dose of CDB-4022 (12.5 mg/kg), dipentylphthalate (DPP; 2200 mg/kg; a Sertoli cell toxicant), or vehicle and were necropsied 3, 6, or 12 h after dosing to determine acute effects. Serum inhibin B levels were suppressed (P < 0.05) by 6 h after CDB-4022 or DPP treatment, but epididymal androgen-binding protein (ABP) levels were not altered (P > 0.05), compared to controls. CDB-4022 and DPP increased (P < 0.05) the percentage of tubules with apoptotic germ cells, particularly differentiating spermatogonia and spermatocytes, by 12 h after dosing. Microscopic examination of the testis indicated a greater degree of vacuolation in Sertoli cells and initial signs of apical germ cell sloughing/shedding by 3 or 12 h after CDB-4022 or DPP treatment, respectively. In a third study, prepubertal male rats were treated with vehicle, 12.5 mg/kg of CDB-4022, or 2200 mg/kg of DPP, and the efferent ducts of the right testis were ligated 23 h before necropsy. Seminiferous tubule fluid secretion (difference in weight of testes), serum inhibin B levels, and ABP levels in the unligated epididymis were reduced (P < 0.05) at 24 and 48 h after dosing in CDB-4022- and DPP-treated rats compared to controls. Collectively, these data suggest that CDB-4022 disrupts spermatogenesis by inducing apoptosis in early stage germ cells via a direct action on the Sertoli cell.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-3363
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1771-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11717140-Androgen-Binding Protein, pubmed-meshheading:11717140-Animals, pubmed-meshheading:11717140-Antispermatogenic Agents, pubmed-meshheading:11717140-Apoptosis, pubmed-meshheading:11717140-Epididymis, pubmed-meshheading:11717140-Female, pubmed-meshheading:11717140-Fertility, pubmed-meshheading:11717140-Indenes, pubmed-meshheading:11717140-Inhibins, pubmed-meshheading:11717140-Leydig Cells, pubmed-meshheading:11717140-Male, pubmed-meshheading:11717140-Organ Size, pubmed-meshheading:11717140-Piperidines, pubmed-meshheading:11717140-Rats, pubmed-meshheading:11717140-Rats, Sprague-Dawley, pubmed-meshheading:11717140-Seminiferous Tubules, pubmed-meshheading:11717140-Sertoli Cells, pubmed-meshheading:11717140-Sperm Count, pubmed-meshheading:11717140-Spermatids, pubmed-meshheading:11717140-Spermatogenesis, pubmed-meshheading:11717140-Spermatogonia, pubmed-meshheading:11717140-Spermatozoa, pubmed-meshheading:11717140-Testis, pubmed-meshheading:11717140-Vacuoles
pubmed:year
2001
pubmed:articleTitle
Disruption of spermatogenesis and Sertoli cell structure and function by the indenopyridine CDB-4022 in rats.
pubmed:affiliation
BIOQUAL, Inc., Rockville, Maryland 20850, USA. sahild@compuserve.com
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.